Drug development
and diagnostics

Choose the relevant keywords from the list to search for research groups on those specific areas. As the search is cumulative, choose only a few keywords for a general search and more keywords for more refined search. To see all research groups, click the selection underneath the list.

Clear All
All research groups

Research Groups and R&D Platforms: Biomarker

Research Group:
Recombinant antibodies and other bioaffinity molecules

Urpo Lamminmäki
urplammi[at]utu.fi

Department of Life Technologies,
University of Turku

Urpo Lamminmäki

Antibodies, Assay development, Basic research, Biomarker, Biotechnology, Cancer, Combinatorial chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, Hit to lead, In Vitro Diagnostics, Infection, Lead optimization, Metabolic diseases, Molecular Biology, Molecular modelling, Nanoparticles, Next-generation sequencing, Ovarian cancer, Point of care, Prostate cancer, Screening, Synthetic Biology, Target discovery

Further information

Pauli Ollikka, Project Coordinator

pauli.ollikka@abo.fi
pauli.ollikka@utu.fi

Drug development and diagnostics is a common research profiling area of the University of Turku and Åbo Akademi University funded by the Academy of Finland. This website is a part of this joint initiative bringing together all information that is related to drug discovery and development or diagnostics from both universities.

Drug developmentand diagnostics

Research Groups and R&D Platforms: Biomarker

Research Group:Recombinant antibodies and other bioaffinity molecules

Further information

Drug development
and diagnostics

Research Group:
Recombinant antibodies and other bioaffinity molecules